JUNSHI BIO (01877) recommends adopting the A-share employee stock ownership plan for 2026.
Kunshin Biology (01877) announces that on April 27, 2026, the board of directors has approved the adoption of the company's 2026 A-share employee shareholding plan. The 2026 A-share employee shareholding plan must be approved by the company's shareholder meeting before it can take effect.
JUNSHI BIO (01877) announced that on April 27, 2026, the board of directors approved the adoption of the company's 2026 A-share employee stock ownership plan. The 2026 A-share employee stock ownership plan must be reviewed and approved by the company's shareholders meeting before it can take effect.
Related Articles
Strategy (MSTR.US) adds $255 million worth of Bitcoin, purchasing pace slows significantly compared to the previous two weeks.
US Stock Market Move | "Concept of optical communication widely declines, POET Technologies (POET.US) drops by nearly 45%."
Montage Technology (06809) net profit attributable to shareholders for the first quarter was 847 million yuan, an increase of 61.3% year-on-year.
Strategy (MSTR.US) adds $255 million worth of Bitcoin, purchasing pace slows significantly compared to the previous two weeks.
US Stock Market Move | "Concept of optical communication widely declines, POET Technologies (POET.US) drops by nearly 45%."
Montage Technology (06809) net profit attributable to shareholders for the first quarter was 847 million yuan, an increase of 61.3% year-on-year.
